Tirzepatide by Eli Lilly is a powerful new antidiabetic drug.
Vonoprazan for Helicobacter pylori eradication and for treating erosive esophagitis, non-erosive gastroesophageal reflux disease (NERD), and gastroesophageal reflux disease (GERD).
Oteseconazole by Mycovia Pharmaceuticals will prevent the risk of recurrent episodes of vulvovaginal candidiasis.
Mavacamten by Bristol-Myers Squibb is a new breath for all patients with obstructive hypertrophic cardiomyopathy.
Teprotumumab by Horizon Therapeutics can really help with proptosis and diplopia in Graves’ disease and beyond.